← Interactive papers
Stem Cell Reviews and Reports · 2026 · Letter

The Buccal Fat Pad: An Accessible Craniofacial Stem Cell Niche with Emerging Regenerative Applications

Mugurel Constantin Rusu · Ivan Varga · Răzvan Costin Tudose · Alexandra Diana Vrapciu · Bogdan Vintilă · Sorin Hostiuc

Stem Cell Rev Rep. 2026;22(4):2015–2018 · doi: 10.1007/s12015-026-11062-3 · PMID 41553660

Interactive scope. This companion maps the publicly verifiable evidence path behind the paper: the buccal fat pad as an intraoral adipose source, the cited mesenchymal/stromal-cell literature, and the progression from laboratory work to early human regenerative applications.
Concept map

Why the buccal fat pad is an attractive regenerative niche

Buccal fat padaccessible intraoral adipose tissue
Adipose-derived stromal cells
Perivascular MSC concept
Bone / osteochondral repair
Maxillofacial translation
Evidence stage 1

In-vitro osteochondral potential

Farré-Guasch et al. studied human buccal-fat-pad adipose stem cells as an oral-access source with potential for osteochondral tissue engineering.

Farré-Guasch et al., 2010 · Tissue Engineering Part C

Translational ladder

From accessible tissue to clinical use

HarvestThe BFP is anatomically accessible through the oral cavity, making it a practical local adipose source in craniofacial surgery.
Cell sourcePublished work cited by the 2026 letter characterises BFP-derived adipose stem/stromal populations and compares them with other adipose sources.
Biological frameThe mesenchymal-cell literature increasingly interprets these cells in relation to perivascular/pericytic niches and local tissue surveillance.
RegenerationThe cited translational studies move toward bone reconstruction, including preliminary human and pilot clinical applications.
What the cited evidence can and cannot establish

Evidence boundary

The publication is a short 2026 letter, not a clinical trial or systematic review. Its cited chain supports biological plausibility and emerging translational use, but it does not by itself establish a standard-of-care regenerative protocol.

Interpret cautiously: cell identity, processing, scaffold/graft combinations, dose, recipient site, and long-term clinical outcomes remain protocol-dependent. The interactive therefore presents an evidence pathway, not a treatment recommendation.
Reference backbone

Five papers cited by the 2026 publication

  1. Farré-Guasch E, Martí-Pagès C, Hernández-Alfaro F, Klein-Nulend J, Casals N. Buccal fat pad as an oral-access source of human adipose stem cells with potential for osteochondral tissue engineering. Tissue Eng Part C Methods. 2010;16:1083–1094.
  2. Broccaioli E, Niada S, Rasperini G, et al. Mesenchymal stem cells from Bichat’s fat pad: in-vitro comparison with adipose-derived stem cells from subcutaneous tissue. BioResearch Open Access. 2013;2:107–117.
  3. Caplan AI. New MSC: MSCs as pericytes are sentinels and gatekeepers. J Orthop Res. 2017;35:1361–1369.
  4. Khojasteh A, Sadeghi N. Application of buccal-fat-pad-derived stem cells with autogenous iliac bone graft in maxillomandibular atrophy: preliminary human study. Int J Oral Maxillofac Surg. 2016;45:864–871.
  5. Bohlouli M, Bastami F, Nokhbatolfoghahei H, Khojasteh A. Buccal-fat-pad stromal vascular fraction as a source in maxillofacial bone regeneration: clinical pilot study. J Plast Reconstr Aesthet Surg. 2023;79:111–121.